English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Being a modern technique with the ability of studying, discovering, probing and analyzing the  expression  of  thousands  genes,  even  the  whole  genome  in  the  only  one  experiment, microarray  proved  to  be  a  powerful  tool  for  cancer  research  especially  at  molecular  level. Employing  the  potential  anticancer  compound  1-(5,7-dimetoxy-2,2-dimetyl-2H-cromen-8-yl)-but-2-en-1-on  (2B2D  in  short) and LU-1,  the human  lung cancer cells as  research objects, we successfully  hybridized  the  cy3/5  incorporated  cDNA  with  Phalanx  HOV5  microarray.  The results  showed  742  genes  that  got  effected with  equal  or  over  two  folds  change  under  2B2D treatment.  Among  -  those,  386  genes  were  up-regulated  while  the  other  356  were  down-regulated. The Nuclear  factor  (erythroid-derived  2,  regulatory  factor X  domain  containing  1, fibroblast  growth  factor  receptor  3  (achondroplasia,  thanatophoric  dwarfism)  and  E2F transcription factor 8 genes were the most stimulated by our compound. The genes that named as Solute carrier  family 7  (cationic amino acid  transporter,  system) member 11,  kelch-like 24 and Hypothetical LOC344887 were the most down in action.

STUDY THE ANTICANCER MECHANISM OF THE PROMISSING COMPOUND 2B2D BY USING MICROARRAY TECHNIQUE